Resected Hepatocellular Carcinoma in a Patient with Crohn’s Disease on Azathioprine
Hepatocellular carcinoma rarely occurs in patients without underlying cirrhosis or liver disease. While inflammatory bowel disease has been linked to certain forms of liver disease, hepatocellular carcinoma is exceedingly rare in these patients. We report the twelfth case of hepatocellular carcinoma...
Main Authors: | Valérie Heron, Kyle Joshua Fortinsky, Gillian Spiegle, Nir Hilzenrat, Andrew Szilagyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2016-05-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/444012 |
Similar Items
-
Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
by: A. V. Poletova, et al.
Published: (2020-10-01) -
Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
by: Tong Li, et al.
Published: (2020-11-01) -
Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn’s Disease Patient
by: Joana Inês Alves da Silva, et al.
Published: (2020-01-01) -
Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
by: Tomonori Hirano, et al.
Published: (2014-05-01) -
Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
by: Jong Won Seo, et al.
Published: (2021-04-01)